OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
Mirjana Urosevic, Jivko Kamarashev, Günter Burg, et al.
Blood (2003) Vol. 103, Iss. 5, pp. 1796-1798
Open Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

Genetic polymorphisms and expression of HLA‐G and its receptors, KIR2DL4 and LILRB1, in non‐small cell lung cancer
Andrzej Wiśniewski, Aneta Kowal, Ewa Wyrodek, et al.
Tissue Antigens (2015) Vol. 85, Iss. 6, pp. 466-475
Closed Access | Times Cited: 31

Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients
Vladimı́ra Ďurmanová, Miroslav Tedla, Dusan Rada, et al.
Diseases (2024) Vol. 12, Iss. 2, pp. 34-34
Open Access | Times Cited: 2

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16

HLA-G expression in hematologic malignancies
Wei‐Hua Yan
Expert Review of Hematology (2010) Vol. 3, Iss. 1, pp. 67-80
Closed Access | Times Cited: 22

Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment
Danli Wu, Isere Kuiaste, Philippe Moreau, et al.
Oncotarget (2015) Vol. 6, Iss. 35, pp. 37385-37397
Open Access | Times Cited: 13

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma
Dorota Jesionek‐Kupnicka, Marcin Bojo, Monika Prochorec–Sobieszek, et al.
Archivum Immunologiae et Therapiae Experimentalis (2015) Vol. 64, Iss. 3, pp. 225-240
Closed Access | Times Cited: 12

Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints
Guillaume Mestrallet, Frédéric Auvré, Chantal Schenowitz, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1438-1438
Open Access | Times Cited: 11

Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1
Jianghong Cheng, Jing Luan, Peng Chen, et al.
Cancer Biomarkers (2020) Vol. 28, Iss. 3, pp. 309-319
Closed Access | Times Cited: 11

Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a diagnostic and prognostic target in certain subtypes of adenocarcinoma
Jianghong Cheng, Xingchun Gao, Xiaohua Zhang, et al.
Medical Hypotheses (2020) Vol. 144, pp. 109863-109863
Closed Access | Times Cited: 10

HLA-G in the skin—Friend or foe?
Mirjana Urosevic
Seminars in Cancer Biology (2007) Vol. 17, Iss. 6, pp. 480-484
Closed Access | Times Cited: 11

Expression of activating natural killer‐cell receptors is a hallmark of the innate‐like T‐cell neoplasm in peripheral T‐cell lymphomas
Yu Uemura, Yasushi Isobe, Akiko Uchida, et al.
Cancer Science (2018) Vol. 109, Iss. 4, pp. 1254-1262
Open Access | Times Cited: 8

Aggressive Cutaneous Cytotoxic Lymphomas
Lorenzo Cerroni, Kevin Gatter, Helmut Kerl
(2009), pp. 97-113
Closed Access | Times Cited: 4

The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
Alan W. Hodges, Rachel Dubuque, Shu‐Hsia Chen, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access

Immune privilege disruption in folliculotropic mycosis fungoides: investigation of major histocompatibility complex antigen expression
Janyana M. D. Deonizio, Joan Guitart, Pedram Yazdan, et al.
International Journal of Dermatology (2018) Vol. 57, Iss. 6, pp. 675-680
Closed Access | Times Cited: 3

Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4
Ching‐Lien Wu, Signe Goul Svendsen, Adrien Rivière, et al.
Human Immunology (2016) Vol. 77, Iss. 9, pp. 720-726
Closed Access | Times Cited: 2

Aggressive Epidermotropic Cutaneous CD8+ Lymphoma
R Massone
(2016)
Closed Access | Times Cited: 1

High incidence of adnexotropism in cytotoxic cutaneous lymphomas
Christina J. Walker, Maria Estela Martínez‐Escala, Timothy L. Tan, et al.
Journal of Cutaneous Pathology (2021) Vol. 48, Iss. 10, pp. 1231-1238
Closed Access | Times Cited: 1

Neoplastic Nodular T-Cell Pattern: An Approach to Diagnosis of Neoplastic Nodular T-Cell Lymphomas of the Skin
Hernani Cualing, Michael B. Morgan, Marshall E. Kadin
Springer eBooks (2014), pp. 269-322
Closed Access

Antigens
Claudio Ortolani
(2011), pp. 1-157
Closed Access

Importance de HLA-G dans les stratégies thérapeutiques anti-cancéreuses
Inès Zidi, Aghleb Bartegi
Therapies (2008) Vol. 63, Iss. 4, pp. 327-332
Closed Access

Trogocytosis in Multiple Myeloma.
Ross Brown, Karieshma Kabani, Shihong Yang, et al.
Blood (2008) Vol. 112, Iss. 11, pp. 1681-1681
Closed Access

Other Cutaneous Cytotoxic Lymphomas
Lorenzo Cerroni, DPhil Kevin Gatter BM, Helmut Kerl
(2004), pp. 66-79
Closed Access

References
Claudio Ortolani
(2021), pp. 301-427
Open Access

Scroll to top